{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:17:54Z","timestamp":1787019474535,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":476,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1177\/2472555220958385","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T21:55:40Z","timestamp":1600379740000},"page":"1108-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4163-9535","authenticated-orcid":false,"given":"Dawid","family":"Maciorowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Z.","family":"El Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3002-1315","authenticated-orcid":false,"given":"Yash","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Medernach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Durvasula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakasha","family":"Kempaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/2472555220958385_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or Moderate Covid-19","author":"Gandhi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2472555220958385_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/CMR.00017-06","article-title":"Bats: Important Reservoir Hosts of Emerging Viruses","volume":"19","author":"Calisher","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1177\/2472555220958385_bib3","doi-asserted-by":"crossref","first-page":"101647","DOI":"10.1016\/j.tmaid.2020.101647","article-title":"Remdesivir for Severe Acute Respiratory Syndrome Coronavirus 2 Causing COVID-19: An Evaluation of the Evidence","author":"Cao","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1177\/2472555220958385_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2169-0","article-title":"Identifying SARS-CoV-2 Related Coronaviruses in Malayan Pangolins","author":"Lam","year":"2020","journal-title":"Nature"},{"key":"10.1177\/2472555220958385_bib5","doi-asserted-by":"crossref","unstructured":"Gupta Y., Maciorowski D., Mathur R., et al. Revealing SARS-CoV-2 Functional Druggability through Multi-Target Cadd Screening of Repurposable Drugs. Revealing SARS-CoV-2 Functional Druggability through Multi-Target Cadd Screening of Repurposable Drugs (accessed Sept 1, 2020).","DOI":"10.20944\/preprints202005.0199.v1"},{"key":"10.1177\/2472555220958385_bib6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM Structure of the 2019-NCoV Spike in the Prefusion Conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1177\/2472555220958385_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1177\/2472555220958385_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"10.1177\/2472555220958385_bib9","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence That TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"10.1177\/2472555220958385_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-Human: Spike Features Determining \u2018Host Jump\u2019 of Coronaviruses SARS-CoV, MERS-CoV, and Beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1177\/2472555220958385_bib11","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of Cathepsin L Prevent Severe Acute Respiratory Syndrome Coronavirus Entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1177\/2472555220958385_bib12","doi-asserted-by":"crossref","first-page":"e76469","DOI":"10.1371\/journal.pone.0076469","article-title":"Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation","volume":"8","author":"Qian","year":"2013","journal-title":"PLoS One"},{"key":"10.1177\/2472555220958385_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging Coronaviruses: Genome Structure, Replication, and Pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1177\/2472555220958385_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/jcm9041225","article-title":"The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control","volume":"9","author":"Helmy","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1177\/2472555220958385_bib15","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The Antiviral Compound Remdesivir Potently Inhibits RNA-Dependent RNA Polymerase from Middle East Respiratory Syndrome Coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1177\/2472555220958385_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, Lopinavir, Emetine, and Homoharringtonine Inhibit SARS-CoV-2 Replication In Vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1177\/2472555220958385_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-NCoV) In Vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1177\/2472555220958385_bib18","doi-asserted-by":"crossref","first-page":"ofaa105","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1177\/2472555220958385_bib19","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-Spectrum Antiviral GS-5734 Inhibits Both Epidemic and Zoonotic Coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1177\/2472555220958385_bib20","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and Therapeutic Remdesivir (GS-5734) Treatment in the Rhesus Macaque Model of MERS-CoV Infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1177\/2472555220958385_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: Recent Insights into Emerging Coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1177\/2472555220958385_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.compbiolchem.2005.04.006","article-title":"Structural Analysis of Inhibition Mechanisms of Aurintricarboxylic Acid on SARS-CoV Polymerase and Other Proteins","volume":"29","author":"Yap","year":"2005","journal-title":"Comput. Biol. Chem."},{"key":"10.1177\/2472555220958385_bib23","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One Severe Acute Respiratory Syndrome Coronavirus Protein Complex Integrates Processive RNA Polymerase and Exonuclease Activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1177\/2472555220958385_bib24","article-title":"Nucleotide Analogues as Inhibitors of SARS-CoV Polymerase","author":"Ju","year":"2020","journal-title":"Pharmacol. Toxicol."},{"key":"10.1177\/2472555220958385_bib25","first-page":"eabc1560","article-title":"Structural Basis for Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1177\/2472555220958385_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2472555220958385_bib27","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2472555220958385_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in Adults with Severe COVID-19: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1177\/2472555220958385_bib29","article-title":"Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1177\/2472555220958385_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a Less Toxic Derivative of Chloroquine, Is Effective in Inhibiting SARS-CoV-2 Infection In Vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1177\/2472555220958385_bib31","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.158.10.4901","article-title":"Chloroquine Inhibits Processing of Tumor Necrosis Factor in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages","volume":"158","author":"Jeong","year":"1997","journal-title":"J. Immunol."},{"key":"10.1177\/2472555220958385_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the Antiviral Activity In Vitro of Some Non-Steroidal Anti-Inflammatory Drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J. Gen. Virol."},{"key":"10.1177\/2472555220958385_bib33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.09.128","article-title":"Mechanisms of Amine Accumulation in, and Egress from, Lysosomes","volume":"1","author":"Goldman","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1177\/2472555220958385_bib34","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of Chloroquine on Viral Infections: An Old Drug against Today\u2019s Diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1177\/2472555220958385_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1177\/2472555220958385_bib36","doi-asserted-by":"crossref","first-page":"e1001176","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture","volume":"6","author":"te Velthuis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1177\/2472555220958385_bib37","doi-asserted-by":"crossref","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and Molecular Modelling Studies Reveal a New Mechanism of Action of Chloroquine and Hydroxychloroquine against SARS-CoV-2 Infection","author":"Fantini","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1177\/2472555220958385_bib38","first-page":"ciaa237","article-title":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1177\/2472555220958385_bib39","doi-asserted-by":"crossref","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In Vitro Testing of Combined Hydroxychloroquine and Azithromycin on SARS-CoV-2 Shows Synergistic Effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1177\/2472555220958385_bib40","article-title":"Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial","author":"Chen","year":"2020","journal-title":"Epidemiology"},{"key":"10.1177\/2472555220958385_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1177\/2472555220958385_bib42","doi-asserted-by":"crossref","first-page":"e00778","DOI":"10.1016\/j.idcr.2020.e00778","article-title":"A. SARS-CoV-2 Infection in a Patient on Chronic Hydroxychloroquine Therapy: Implications for Prophylaxis","volume":"20","author":"Dousa","year":"2020","journal-title":"IDCases"},{"key":"10.1177\/2472555220958385_bib43","doi-asserted-by":"crossref","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and Microbiological Effect of a Combination of Hydroxychloroquine and Azithromycin in 80 COVID-19 Patients with at Least a Six-Day Follow Up: A Pilot Observational Study","author":"Gautret","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1177\/2472555220958385_bib44","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19","author":"Geleris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2472555220958385_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8630","article-title":"Association of Treatment with Hydroxychloroquine or Azithromycin with In-Hospital Mortality in Patients with COVID-19 in New York State","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"10.1177\/2472555220958385_bib46","doi-asserted-by":"crossref","first-page":"m1844","DOI":"10.1136\/bmj.m1844","article-title":"Clinical Efficacy of Hydroxychloroquine in Patients with Covid-19 Pneumonia Who Require Oxygen: Observational Comparative Study Using Routine Care Data","author":"Mah\u00e9vas","year":"2020","journal-title":"BMJ"},{"key":"10.1177\/2472555220958385_bib47","article-title":"Anticoagulant Treatment Is Associated with Decreased Mortality in Severe Coronavirus Disease 2019 Patients with Coagulopathy","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1177\/2472555220958385_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5114\/reum.2018.76904","article-title":"Antimalarials\u2014Are They Effective and Safe in Rheumatic Diseases?","volume":"56","author":"Ha\u0142adyj","year":"2018","journal-title":"Reumatologia"},{"key":"10.1177\/2472555220958385_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047521","article-title":"Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment","author":"Roden","year":"2020","journal-title":"Circulation"},{"key":"10.1177\/2472555220958385_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1834","article-title":"S. Risk of QT Interval Prolongation Associated with Use of Hydroxychloroquine with or without Concomitant Azithromycin among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1177\/2472555220958385_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of QT Intervals in a Case Series of Patients with Coronavirus Disease 2019 (COVID-19) Infection Treated with Hydroxychloroquine Alone or in Combination with Azithromycin in an Intensive Care Unit","author":"Bessi\u00e8re","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1177\/2472555220958385_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of Lopinavir\/Ritonavir in the Treatment of SARS: Initial Virological and Clinical Findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1177\/2472555220958385_bib53","first-page":"399","article-title":"Treatment of Severe Acute Respiratory Syndrome with Lopinavir\/Ritonavir: A Multicentre Retrospective Matched Cohort Study","volume":"9","author":"Chan","year":"2003","journal-title":"Hong Kong Med. J."},{"key":"10.1177\/2472555220958385_bib54","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/2472555220958385_bib55","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with Lopinavir\/Ritonavir or Interferon-\u03921b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1177\/2472555220958385_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome Composition and Divergence of the Novel Coronavirus (2019-NCoV) Originating in China","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1177\/2472555220958385_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-Coronavirus Papain-Like Protease: Structure, Function and Inhibition by Designed Antiviral Compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1177\/2472555220958385_bib58","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A Noncovalent Class of Papain-Like Protease\/Deubiquitinase Inhibitors Blocks SARS Virus Replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1177\/2472555220958385_bib59","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir\u2013Ritonavir in Adults Hospitalized with Severe Covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2472555220958385_bib60","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"10.1177\/2472555220958385_bib61","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3346\/jkms.2020.35.e79","article-title":"Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: The Application of Lopinavir\/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"10.1177\/2472555220958385_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00296-020-04584-7","article-title":"Coronavirus Disease 19 (COVID-19) Complicated with Pneumonia in a Patient with Rheumatoid Arthritis Receiving Conventional Disease-Modifying Antirheumatic Drugs","volume":"40","author":"Song","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1177\/2472555220958385_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.03.032","article-title":"Lopinavir\/Ritonavir Did Not Shorten the Duration of SARS CoV-2 Shedding in Patients with Mild Pneumonia in Taiwan","author":"Cheng","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1177\/2472555220958385_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.060","article-title":"Arbidol Monotherapy Is Superior to Lopinavir\/Ritonavir in Treating COVID-19","author":"Zhu","year":"2020","journal-title":"J. Infect."},{"key":"10.1177\/2472555220958385_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple Combination of Interferon Beta-1b, Lopinavir\u2013Ritonavir, and Ribavirin in the Treatment of Patients Admitted to Hospital with COVID-19: An Open-Label, Randomised, Phase 2 Trial","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1177\/2472555220958385_bib66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00011-020-01342-0","article-title":"The Correlation between Viral Clearance and Biochemical Outcomes of 94 COVID-19 Infected Discharged Patients","volume":"69","author":"Yuan","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1177\/2472555220958385_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol Combined with LPV\/r versus LPV\/r Alone against Corona Virus Disease 2019: A Retrospective Cohort Study","author":"Deng","year":"2020","journal-title":"J. Infect."},{"key":"10.1177\/2472555220958385_bib68","first-page":"3390","article-title":"Clinical Efficacy of Lopinavir\/Ritonavir in the Treatment of Coronavirus Disease 2019","volume":"24","author":"Ye","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1177\/2472555220958385_bib69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/Ritonavir: A Review of Its Use in the Management of HIV Infection","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs"},{"key":"10.1177\/2472555220958385_bib70","doi-asserted-by":"crossref","first-page":"104854","DOI":"10.1016\/j.phrs.2020.104854","article-title":"Current Targeted Therapeutics against COVID-19: Based on First-Line Experience in China","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555220958385","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2472555220958385","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222066485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222066485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555220958385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:53:32Z","timestamp":1762862012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222066485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2472555222066485"],"URL":"https:\/\/doi.org\/10.1177\/2472555220958385","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2472555220958385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}